APA

Musolino A., Naldi N., Dieci M. V., Zanoni D., Rimanti A., Boggiani D., Sgargi P., Generali D. G., Piacentini F., Ambroggi M., Cagossi K., Gianni L., Sarti S., Bisagni G., Ardizzoni A., Conte P. F. & Guarneri V. (20170605). Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer. : The pharmacogenomics journal.

Chicago

Musolino A, Naldi N, Dieci M V, Zanoni D, Rimanti A, Boggiani D, Sgargi P, Generali D G, Piacentini F, Ambroggi M, Cagossi K, Gianni L, Sarti S, Bisagni G, Ardizzoni A, Conte P F and Guarneri V. 20170605. Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer. : The pharmacogenomics journal.

Harvard

Musolino A., Naldi N., Dieci M. V., Zanoni D., Rimanti A., Boggiani D., Sgargi P., Generali D. G., Piacentini F., Ambroggi M., Cagossi K., Gianni L., Sarti S., Bisagni G., Ardizzoni A., Conte P. F. and Guarneri V. (20170605). Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer. : The pharmacogenomics journal.

MLA

Musolino A, Naldi N, Dieci M V, Zanoni D, Rimanti A, Boggiani D, Sgargi P, Generali D G, Piacentini F, Ambroggi M, Cagossi K, Gianni L, Sarti S, Bisagni G, Ardizzoni A, Conte P F and Guarneri V. Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer. : The pharmacogenomics journal. 20170605.